UPDATED: Are You Sitting Down?
Good--because I wouldn't want the shock from this to cause you to fall down and hurt yourself.
What a difference an Election Hoax can make--in medical science, no less! From the:
Nov 2020 Special Meeting of the AMA House of Delegates - Handbook Addendum
It turns out the American Medical Association passed the following Resolution--HCQ is good:
Resolution: 509 (November 2020)
Page 3 of 6
Whereas, The COVID-19 pandemic is a serious medical issue, people are dying, and physicians must be able to perform as sagacious prescribers; therefore be it
RESOLVED, That our American Medical Association rescind its statement calling for physicians to stop prescribing hydroxychloroquine and chloroquine until sufficient evidence becomes available to conclusively illustrate that the harm associated with use outweighs benefit early in the disease course. Implying that such treatment is inappropriate contradicts AMA Policy H-120.988, “Patient Access to Treatments Prescribed by Their Physicians,” that addresses off label prescriptions as appropriate in the judgement of the prescribing physician (Directive to Take Action); and be it further
RESOLVED, That our AMA rescind its joint statement with the American Pharmacists Association and American Society of Health System Pharmacists, and update it with a joint statement notifying patients that further studies are ongoing to clarify any potential benefit of hydroxychloroquine and combination therapies for the treatment of COVID-19 (Directive to Take Action); and be it further
RESOLVED, That our AMA reassure the patients whose physicians are prescribing hydroxychloroquine and combination therapies for their early-stage COVID-19 diagnosis by issuing an updated statement clarifying our support for a physician’s ability to prescribe an FDA21 approved medication for off label use, if it is in her/his best clinical judgement, with specific reference to the use of hydroxychloroquine and combination therapies for the treatment of the earliest stage of COVID-19 (Directive to Take Action); and be it further
RESOLVED, That our AMA take the actions necessary to require local pharmacies to fill valid prescriptions that are issued by physicians and consistent with AMA principles articulated in AMA Policy H-120.988, “Patient Access to Treatments Prescribed by Their Physicians,” including working with the American Pharmacists Association and American Society of Health System Pharmacists. (Directive to Take Action)
Is there some way to put these people on the SCOTUS?
UIPDATE: I'm pasting in a comment that clarifies what happened.
What you've illustrated is a resolution submitted for consideration at the AMA's November 2020 special meeting. Here's what happened, according to proceedings from that meeting.
Reference Committee E met and "reviewed passionate and mixed testimony from both the online 46 testimony and in the live hearing on this resolution." It decided, "your Reference Committee recommends that Resolution 509 not be adopted."
https://www.ama-assn.org/system/files/2020-11/nov20-ref-com-e-annotated.pdf pages 15-16
On page 20 of this document, you can find that when the AMA House of Delegates voted, it did not adopt this resolution, and it reaffirmed their existing position.
https://www.ama-assn.org/system/files/2020-12/nov-s20-resolutions.pdf
The existing position, contained in policy H-120.988, states, in part, "Our AMA confirms its strong support for the autonomous clinical decision-making authority of a physician and that a physician may lawfully use an FDA approved drug product or medical device for an off-label indication when such use is based upon sound scientific evidence or sound medical opinion ..."
My guess is that this leaves the decision very much up to State medical authorities.